Bernd R. Seizinger is Director at Aprea Therapeutics, Inc. (APRE). They have made 7 open-market trades across 3 companies since 2022, most recently 2026-06-16.
CIK 0001789042
7 open-market purchases totalling $440K since 2022, never a sale. Across 7 scored buys the stock is down 6.3% at ninety days, and 12.5 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ONCY | 566,991 | $283K |
| APTO | 17,000 | $29K |
| APRE | 48,910 | $29K |
| Total | $341K |
Shares reported on the most recent Form 4, priced at the 2026-06-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 29% | 29% | 43% |
| Avg Move | -2.0% | -6.5% | -6.3% |
| Alpha | -3.2% | -5.8% | -12.5% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONCY | BUY | 2026-02-11 | 2026-02-13 | $0.84 | $84K | -1.4% | -7.8% | -19.0% |
| ONCY | BUY | 2026-01-16 | 2026-01-20 | $1.04 | $104K | -5.7% | -3.8% | +7.2% |
| APRE | BUY | 2024-10-11 | 2024-10-15 | $2.68 | $27K | -5.6% | -22.5% | -20.8% |
| APRE | BUY | 2024-03-13 | 2024-03-14 | $7.29 | $100K | +5.9% | +5.5% | -22.7% |
| APTO | BUY | 2023-09-22 | 2023-09-25 | $3.14 | $53K | -11.7% | -16.2% | -25.2% |
| APRE | BUY | 2023-06-06 | 2023-06-08 | $3.66 | $37K | -9.0% | -21.4% | +8.4% |
| APRE | BUY | 2022-05-18 | 2022-05-19 | $0.71 | $36K | +13.8% | +20.7% | +28.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.